Patents by Inventor Jin Hee Ahn

Jin Hee Ahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220208467
    Abstract: A multilayer electronic component includes an external electrode having a connection portion and a band portion. An organic layer is disposed between an electrode layer and a plating layer of the band portion of the external electrode, and a conductive resin layer is disposed between the electrode layer and the plating layer of the connection portion of the external electrode.
    Type: Application
    Filed: September 9, 2021
    Publication date: June 30, 2022
    Applicant: SAMSUNG ELECTRO-MECHANICS CO., LTD.
    Inventors: Do Young Jeong, Jin Mo Ahn, Eun Hee Jeong, Ga Young An
  • Patent number: 11336901
    Abstract: An intra prediction method according to the present invention comprises the following steps: performing a directional prediction using at least one of a neighboring pixel of a current block and a left upper corner pixel positioned at a left upper corner of the current block so as to obtain a first prediction value for the current block; obtaining a second prediction value for the current block using the reference sample positioned in the current block; and weighted summing the first prediction value and the second prediction value using a weighting matrix so as to obtain a final prediction value for the current block. According to the present invention, image encoding/decoding efficiency may be improved.
    Type: Grant
    Filed: September 15, 2020
    Date of Patent: May 17, 2022
    Assignee: Electronics and Telecommunications Research Institute
    Inventors: Jin Ho Lee, Hui Yong Kim, Sung Chang Lim, Jong Ho Kim, Ha Hyun Lee, Se Yoon Jeong, Suk Hee Cho, Jin Soo Choi, Jin Woong Kim, Chie Teuk Ahn
  • Publication number: 20220150499
    Abstract: A method for decoding an image, the method including receiving a bitstream including image information, decoding base block size information on a size of a base block, and a residual quantization parameter of a decoding object unit, from the bitstream, deriving a predicted quantization parameter of the decoding object unit based on the base block size information, deriving a quantization parameter of the decoding object unit based on the predicted quantization parameter and the residual quantization parameter, and decoding the decoding object unit based on the quantization parameter of the decoding object unit.
    Type: Application
    Filed: January 21, 2022
    Publication date: May 12, 2022
    Inventors: Sung Chang LIM, Hui Yong KIM, Se Yoon JEONG, Suk Hee CHO, Jong Ho KIM, Ha Hyun LEE, Jin Ho LEE, Jin Soo CHOI, Jin Woong KIM, Chie Teuk AHN
  • Publication number: 20220149284
    Abstract: In a method for manufacturing conductive polymer electrode by using drop casting, a conductive material is dispersed in a solution, to form a first mixing solution. A first polymer is added and dispersed to the first mixing solution, to form a second mixing solution. A second polymer solution is added and dispersed to the second mixing solution, to form a third mixing solution. The third mixing solution is dropped on a hot plate using a pipette and a solution of the third mixing solution is evaporated, to form a conductive polymer. The adhesive patch is formed. The adhesive patch is attached to the conductive polymer.
    Type: Application
    Filed: April 3, 2019
    Publication date: May 12, 2022
    Applicant: OSONG MEDICAL INNOVATION FOUNDATION
    Inventors: Ha Chul JUNG, Da Hye KWON, Jin Hee MOON, Young Jin KIM, Jin Woo AHN, Won Jung CHOI, Seung A LEE, A Hee KIM, Ha Na PARK
  • Publication number: 20210155634
    Abstract: The present invention relates to a novel tryptophan hydroxylase inhibitor and a pharmaceutical composition including same, wherein the novel tryptophan hydroxylase inhibitor has an excellent inhibitory effect on TPH1, and thus can be usefully used for the prevention or treatment of disorders, such as metabolic disorders, cancer, digestive or cardiovascular system disorders, related to TPH1 activity. In particular, the novel tryptophan hydroxylase inhibitor has an excellent treatment effect on inflammatory bowel disorders, and thus can be usefully used for the treatment of inflammatory bowel disorder.
    Type: Application
    Filed: August 24, 2018
    Publication date: May 27, 2021
    Inventors: Jin Hee Ahn, Hail Kim, Jaemyoung Suh, In-Kyu Lee, Kwang-eun Kim, Kun-Young Park, Eun Jung Bae, Ko Eun Shong, Suvarna Haus-habhau Pagire, Ajin Lim, Jae-Han Jeon, Haushabhau Shivaji Pagire, Haiying Zhang, Myung-Hwa Kim, Jung-In Pyo
  • Publication number: 20210070718
    Abstract: The present invention relates to a novel phenylsulfonyl oxazole derivative and a use thereof and specifically, to a compound represented by Chemical Formula 1 in the present specification or a pharmaceutically acceptable salt thereof, and to a use thereof for prevention, treatment, or improvement of neurodegenerative disease.
    Type: Application
    Filed: January 10, 2019
    Publication date: March 11, 2021
    Inventors: Jae Sung BAE, Hee Kyung JIN, Myung Shik LEE, Hye Jin LIM, Jin Hee AHN, Haushabhau Shivaji PAGIRE, Min Jae Lee
  • Patent number: 10881642
    Abstract: Provided are a compound of chemical formula 1 or 2 and a use thereof. The compound can be advantageously used in the prevention or treatment of metabolic diseases including type 2 diabetes, insulin resistance, or obesity, on the basis of a mechanism of autophagy activation through the promotion of lysosome production.
    Type: Grant
    Filed: June 29, 2017
    Date of Patent: January 5, 2021
    Assignees: Industry-Academic Cooperation Foundation, Yonsei University, Gwangju Institute of Science and Technology
    Inventors: Myung-Shik Lee, Hyejin Lim, Young Eui Jeon, Jin Hee Ahn, H. S. Pagire
  • Publication number: 20190336483
    Abstract: Provided are a compound of chemical formula 1 or 2 and a use thereof. The compound can be advantageously used in the prevention or treatment of metabolic diseases including type 2 diabetes, insulin resistance, or obesity, on the basis of a mechanism of autophagy activation through the promotion of lysosome production.
    Type: Application
    Filed: June 29, 2017
    Publication date: November 7, 2019
    Applicants: Industry-Academic Cooperation Foundation, Yonsei University, Gwangju Institute of Science and Technology
    Inventors: Myung-Shik LEE, Hyejin LIM, Young Eui JEON, Jin Hee AHN, H.S. PAGIRE
  • Publication number: 20180282053
    Abstract: In a finished product used by coupling a 2-piece bottle cap formed of a cover and a body to the opening of a bottle, everything relating to the bottle cap having the body or the cover of various structures in which a desired number of the contents stored in the inner space of the bottle is left remained in a keeping groove when the cover coupled by screw threads to the body is opened after the finished product is turned 90-180 degrees upside down from an upright standing position and then rotated to the upright position, is disclosed.
    Type: Application
    Filed: July 13, 2016
    Publication date: October 4, 2018
    Inventor: Jin Hee AHN
  • Patent number: 9321728
    Abstract: The present invention relates to a beta-alanine derivative, pharmaceutically acceptable salts thereof, and a pharmaceutical composition including the same as an active ingredient. The novel beta-alanine derivative and pharmaceutically acceptable salts thereof according to the present invention may effectively inhibit the activity of DGAT1, which is an enzyme serving as a catalyst in the final step of the synthesis of neutral lipids, to thereby be effectively used as a pharmaceutical composition for preventing or treating various lipid metabolism-related disorders selected from the group consisting of obesity, dyslipidemia, fatty liver, insulin resistance syndrome, and hepatitis.
    Type: Grant
    Filed: April 25, 2013
    Date of Patent: April 26, 2016
    Assignees: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY, HANDOK PHARMACEUTICALS CO., LTD.
    Inventors: Jin Hee Ahn, H. S. Pagire, Sang Dal Rhee, Ki Young Kim, Won Hoon Jung, Myung-Ae Bae, Jin Sook Song, Kwang-Rok Kim, Hyun Jung Kwak
  • Publication number: 20150329504
    Abstract: The present invention relates to a beta-alanine derivative, pharmaceutically acceptable salts thereof, and a pharmaceutical composition including the same as an active ingredient. The novel beta-alanine derivative and pharmaceutically acceptable salts thereof according to the present invention may effectively inhibit the activity of DGAT1, which is an enzyme serving as a catalyst in the final step of the synthesis of neutral lipids, to thereby be effectively used as a pharmaceutical composition for preventing or treating various lipid metabolism-related disorders selected from the group consisting of obesity, dyslipidemia, fatty liver, insulin resistance syndrome, and hepatitis.
    Type: Application
    Filed: April 25, 2013
    Publication date: November 19, 2015
    Inventors: Jin Hee AHN, H.S. PAGIRE, Sal Dal RHEE, Ki Young KIM, Won Hoon JUNG, Myung-Ae BAE, Jin Sook SONG, Kwang-Rok KIM, Hyun Jung KWAK
  • Patent number: 9073906
    Abstract: Provided is a sulfamide derivative having an adamantyl group represented by the following Formula 1, or a pharmaceutically acceptable salt thereof. The sulfamide derivative suppresses the activity of 11?-hydroxysteroid dehydrogenase type 1 (11?-HSD1), and is useful in the treatment of various diseases that are mediated by 11?-HSD1.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: July 7, 2015
    Assignee: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Ki Young Kim, Jin Hee Ahn, Seung Kyu Kang, Sang Dal Rhee, Myung Ae Bae, Sung Hoon Ahn, Hee Youn Kim, Won Hoon Jung, Nam Sook Kang
  • Publication number: 20140024636
    Abstract: Provided is a sulfamide derivative having an adamantyl group represented by the following Formula 1, or a pharmaceutically acceptable salt thereof. The sulfamide derivative suppresses the activity of 11?-hydroxysteroid dehydrogenase type 1 (11?-HSD1), and is useful in the treatment of various diseases that are mediated by 11?-HSD1.
    Type: Application
    Filed: March 30, 2012
    Publication date: January 23, 2014
    Applicant: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Ki Young Kim, Jin Hee Ahn, Seung Kyu Kang, Sang Dal Rhee, Myung Ae Bae, Sung Hoon Ahn, Hee Youn Kim, Won Hoon Jung, Nam Sook Kang
  • Patent number: 8621797
    Abstract: A steel structure including pre-stressing brackets for improving load-carrying capacity and serviceability comprises: a steel girder; a plurality of connecting brackets connected to the bottom surface of the steel girder spaced and apart from one; and a cover plate connected to the bottom surfaces of the connecting brackets. Since the cover plate is installed regardless of the connecting portion of the steel girder, pre-stressing section can be consecutively formed therefore pre-stress effect is improved. Moreover, since the connecting brackets space the cover plate a constant distance from the steel girder, the moment of inertia is increased so the span of a bridge might be increased.
    Type: Grant
    Filed: May 4, 2011
    Date of Patent: January 7, 2014
    Assignees: Yooho Development & Construction Co. Ltd., Industry-Academic Cooperation Foundation, Yonsei University
    Inventors: Sang Hyo Kim, Jin Hee Ahn, Jung Ho Yoo, Seung Soo Han, Chang Keon Cho, Kyu Tae Choi
  • Publication number: 20130097947
    Abstract: A steel structure including pre-stressing brackets for improving load-carrying capacity and serviceability comprises: a steel girder; a plurality of connecting brackets connected to the bottom surface of the steel girder spaced and apart from one; and a cover plate connected to the bottom surfaces of the connecting brackets. Since the cover plate is installed regardless of the connecting portion of the steel girder, pre-stressing section can be consecutively formed therefore pre-stress effect is improved. Moreover, since the connecting brackets space the cover plate a constant distance from the steel girder, the moment of inertia is increased so the span of a bridge might be increased.
    Type: Application
    Filed: May 4, 2011
    Publication date: April 25, 2013
    Inventors: Sang Hyo Kim, Jin Hee Ahn, Jung Ho Yoo, Seung Soo Han, Chang Keon Cho, Kyu Tae Choi
  • Patent number: 8148541
    Abstract: Disclosed herein are rhodanine derivatives, a method for the preparation thereof, and a pharmaceutical composition containing the same. The rhodanine derivatives have inhibitory activity against protein phosphatases (PPase) such as PTP1B, Prl-3, LAR, CD45, Cdc25A, Cdc25B, Cdc25C, Yop, PP1 and VHR, and can be applied for the prevention and treatment of PPase-caused diseases, including autoimmune diseases, diabetes, impaired glucose intolerance, insulin resistance, obesity, cancers, etc. when the inhibitory activity thereof is modulated.
    Type: Grant
    Filed: December 8, 2006
    Date of Patent: April 3, 2012
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Seong Eon Ryu, Seung Jun Kim, Dae Gwin Jeong, Sang Hyeup Lee, Suk Kyeong Jung, Hwan Mook Kim, Song Kyu Park, Ki Ho Lee, Chang Woo Lee, Joong-Kwon Choi, Jin Hee Ahn
  • Publication number: 20100237072
    Abstract: Disclosed is a closure of a vessel that is prevented from being arbitrarily opened.
    Type: Application
    Filed: October 24, 2008
    Publication date: September 23, 2010
    Inventor: Jin-Hee Ahn
  • Patent number: 7745439
    Abstract: The inventive indene derivatives of formula (I) are capable of selectively modulating the activities of peroxisome proliferator activated receptors (PPARs), causing no adverse side effects, and thus, they are useful for the treatment and prevention of disorders modulated by PPARs, i.e., metabolic syndromes such as diabetes, obesity, arteriosclerosis, hyperlipidemia, hyperinsulinism and hypertension, inflammatory diseases such as osteoporosis, liver cirrhosis and asthma, and cancer.
    Type: Grant
    Filed: April 12, 2005
    Date of Patent: June 29, 2010
    Assignees: Korea Research Institute of Chemical Technology, Jeil Pharm. Co., Ltd., Korea Research Institute of Bioscience and Biotechnology, CJ Corp.
    Inventors: Hyae Gyeong Cheon, Sung-Eun Yoo, Sung Soo Kim, Sung-Don Yang, Kwang-Rok Kim, Sang Dal Rhee, Jin Hee Ahn, Seung Kyu Kang, Won Hoon Jung, Sung Dae Park, Nam Gee Kim, Sun Mee Kim, Kil Woong Mo, Jae Mok Lee, Hye Jung Kang, Koun Ho Lee, Jong Hoon Kim, Jeong-Hyung Lee, Seung Jun Kim
  • Patent number: 7741323
    Abstract: An indene derivative for selectively modulating the activities of peroxisome proliferator activated receptors (PPARs) having the following formula (I): wherein, R1 is C1-6 alkyl, C1-6 alkenyl, or C3-6 cycloalkyl, each of which is unsubstituted or substituted with one or more phenyl groups; R2 is H, CN, CO2Ra, CH2CO2Ra, CONRbRc, or phenyl; R3 is C1-6 alkyl, C3-6 cycloalkyl, naphthyl, phenyl, being each unsubstituted or substituted with one or more substituents selected from the group consisting of halogen, CN, NH2, NO2, ORa, phenyloxy, C1-6 alkyl, and C3-6 cycloalkyl; and R4, R5, R6, and R7 are each independently H, OH, OSO2CH3, O(CH2)mRe, CH2Rf, OCOCH2ORg, OCH2CH2ORg, OCH2CH?CHRg, or pyridine-2-yloxy, or R5 and R6 together form OCH2O.
    Type: Grant
    Filed: April 13, 2005
    Date of Patent: June 22, 2010
    Assignees: Korea Research Institute of Chemical Technology, Jeil Pharm. Co., Ltd., Korea Research Institute of Bioscience and Biotechnology, CJ Corp.
    Inventors: Hyae Gyeong Cheon, Sung-Eun Yoo, Sung Soo Kim, Sung-Don Yang, Kwang-Rok Kim, Sang Dal Rhee, Jin Hee Ahn, Seung Kyu Kang, Won Hoon Jung, Sung Dae Park, Nam Gee Kim, Jang Hyuk Lee, Sun Chul Huh, Jae Mok Lee, Seog Beom Song, Soon Ji Kwon, Jong Hoon Kim, Jeong-Hyung Lee, Seung Jun Kim
  • Publication number: 20100048570
    Abstract: The present invention relates to novel 2-carbonyl-3-acyl-1,3-thiazolidines having a ?-amino group on the acyl chain, in free, prodrug form or pharmaceutically acceptable salt thereof, including their enantiomers, diastereomers and racemates, as efficient inhibitors against DPP-IV. The invention further relates to the pharmaceutical compositions comprising the disclosed compounds. The present invention also relates to methods for preparing the disclosed compounds and for treating DPP-IV-mediated diseases.
    Type: Application
    Filed: January 16, 2008
    Publication date: February 25, 2010
    Applicants: Kainos Medicine, Inc, Korea Research Institute of Chemical Technology, Yungjin Pharmaceutical Company, Ltd
    Inventors: Sung Soo Kim, Jin Hee Ahn, Hyae Gyeong Cheon, Sang Dal Rhee, Nam Sook Kang, Ki Young Kim, Seung Kyu Kang, Won Hoon Jung, Sung Gyu Kim, Sun Young Kim, Jae Hong Kweon, Sang Kwon Sohn, Min Ki Shin, Ni Na Ha